State Street’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Sell |
3,371,912
-744,884
| -18% | -$5.35M | ﹤0.01% | 2083 |
|
|
2025
Q1 | $24.7M | Buy |
4,116,796
+198,666
| +5% | +$1.19M | ﹤0.01% | 2008 |
|
|
2024
Q4 | $30.6M | Buy |
3,918,130
+686,668
| +21% | +$5.36M | ﹤0.01% | 1973 |
|
|
2024
Q3 | $34.9M | Sell |
3,231,462
-605,500
| -16% | -$6.54M | ﹤0.01% | 1881 |
|
|
2024
Q2 | $32.3M | Sell |
3,836,962
-3,789,907
| -50% | -$31.9M | ﹤0.01% | 1888 |
|
|
2024
Q1 | $51.3M | Buy |
7,626,869
+3,476,254
| +84% | +$23.4M | ﹤0.01% | 1716 |
|
|
2023
Q4 | $24.4M | Buy |
4,150,615
+1,182,980
| +40% | +$6.96M | ﹤0.01% | 2100 |
|
|
2023
Q3 | $28.9M | Sell |
2,967,635
-160,468
| -5% | -$1.56M | ﹤0.01% | 1938 |
|
|
2023
Q2 | $37M | Sell |
3,128,103
-299,611
| -9% | -$3.55M | ﹤0.01% | 1853 |
|
|
2023
Q1 | $37M | Sell |
3,427,714
-833,667
| -20% | -$9M | ﹤0.01% | 1841 |
|
|
2022
Q4 | $49.3M | Buy |
4,261,381
+852,779
| +25% | +$9.86M | ﹤0.01% | 1651 |
|
|
2022
Q3 | $50.9M | Buy |
3,408,602
+2,714,447
| +391% | +$40.5M | ﹤0.01% | 1588 |
|
|
2022
Q2 | $6.26M | Buy |
694,155
+68,523
| +11% | +$618K | ﹤0.01% | 2982 |
|
|
2022
Q1 | $4.69M | Buy |
625,632
+27,624
| +5% | +$207K | ﹤0.01% | 3212 |
|
|
2021
Q4 | $5.13M | Buy |
598,008
+14,993
| +3% | +$129K | ﹤0.01% | 3231 |
|
|
2021
Q3 | $4.9M | Buy |
583,015
+76,158
| +15% | +$640K | ﹤0.01% | 3249 |
|
|
2021
Q2 | $4.11M | Buy |
506,857
+486,657
| +2,409% | +$3.95M | ﹤0.01% | 3339 |
|
|
2021
Q1 | $177K | Hold |
20,200
| – | – | ﹤0.01% | 3858 |
|
|
2020
Q4 | $227K | Buy |
+20,200
| New | +$227K | ﹤0.01% | 3739 |
|
|
2019
Q2 | – | Sell |
-215,459
| Closed | -$946K | – | 3825 |
|
|
2019
Q1 | $946K | Buy |
215,459
+43,302
| +25% | +$190K | ﹤0.01% | 3348 |
|
|
2018
Q4 | $757K | Buy |
172,157
+104,317
| +154% | +$459K | ﹤0.01% | 3378 |
|
|
2018
Q3 | $699K | Buy |
67,840
+44,740
| +194% | +$461K | ﹤0.01% | 3444 |
|
|
2018
Q2 | $331K | Buy |
+23,100
| New | +$331K | ﹤0.01% | 3516 |
|